Condensed Statements of Operations and Comprehensive Loss - USD ($) shares in Thousands, $ in Thousands	3 Months Ended
	Mar. 31, 2026	Mar. 31, 2025
Operating Expenses:
Research and development	$ 9,734	$ 12,138
General and administrative	4,741	5,203
Total operating expenses	14,475	17,341
Loss from operations	(14,475)	(17,341)
Other income, net:
Interest income	920	1,585
Other expense		(2)
Total other income, net	920	1,583
Net loss	(13,555)	(15,758)
Comprehensive loss:
Net loss	(13,555)	(15,758)
Unrealized loss on short-term investments	(87)	(89)
Comprehensive loss	$ (13,642)	$ (15,847)
Net loss per share, basic	$ (0.6)	$ (0.71)
Net loss per share, diluted	$ (0.6)	$ (0.71)
Shares used in calculation, basic	22,407	22,300
Shares used in calculation, diluted	22,407	22,300